Wells Fargo & Company MN Sells 28,693 Shares of National Research Co. (NASDAQ:NRC)

Wells Fargo & Company MN trimmed its position in shares of National Research Co. (NASDAQ:NRC - Free Report) by 16.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 143,145 shares of the company's stock after selling 28,693 shares during the period. Wells Fargo & Company MN owned 0.61% of National Research worth $2,525,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in NRC. State Street Corp grew its position in National Research by 4.0% during the 3rd quarter. State Street Corp now owns 363,438 shares of the company's stock worth $8,351,000 after purchasing an additional 14,144 shares in the last quarter. Barclays PLC boosted its holdings in National Research by 65.6% in the third quarter. Barclays PLC now owns 51,331 shares of the company's stock worth $1,175,000 after purchasing an additional 20,331 shares in the last quarter. Geode Capital Management LLC lifted its position in National Research by 3.2% during the 3rd quarter. Geode Capital Management LLC now owns 420,733 shares of the company's stock worth $9,619,000 after acquiring an additional 13,039 shares during the last quarter. Principal Financial Group Inc. bought a new position in shares of National Research in the third quarter worth about $248,000. Finally, JPMorgan Chase & Co. lifted its position in shares of National Research by 8.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 17,194 shares of the company's stock worth $393,000 after purchasing an additional 1,373 shares during the last quarter. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

National Research Stock Performance

NASDAQ NRC traded down $0.73 during trading on Wednesday, hitting $11.15. The company's stock had a trading volume of 3,302 shares, compared to its average volume of 93,965. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30. The firm has a 50 day moving average price of $13.12 and a 200 day moving average price of $16.43. The firm has a market cap of $255.73 million, a P/E ratio of 10.57 and a beta of 0.41. National Research Co. has a 52 week low of $9.76 and a 52 week high of $35.81.

National Research (NASDAQ:NRC - Get Free Report) last announced its quarterly earnings results on Monday, April 28th. The company reported $0.25 EPS for the quarter. The business had revenue of $33.55 million for the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%.

National Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 4.31%. The ex-dividend date of this dividend is Friday, June 27th. National Research's dividend payout ratio is currently 45.71%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.